Omalizumab for asthma

N Engl J Med. 2006 Jun 22;354(25):2689-95. doi: 10.1056/NEJMct055184.
No abstract available

Publication types

  • Review

MeSH terms

  • Adolescent
  • Allergens / immunology
  • Anti-Asthmatic Agents / adverse effects
  • Anti-Asthmatic Agents / immunology
  • Anti-Asthmatic Agents / therapeutic use*
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Asthma / drug therapy*
  • Asthma / immunology
  • Humans
  • Immunoglobulin E / immunology
  • Male
  • Omalizumab
  • Practice Guidelines as Topic

Substances

  • Allergens
  • Anti-Asthmatic Agents
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Omalizumab
  • Immunoglobulin E